Bristol-Myers Squibb
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
CEOChristopher S. Boerner
CEOChristopher S. Boerner
Employees34,100
Employees34,100
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1933
Founded1933
Employees34,100
Employees34,100
BMY Key Statistics
Market cap95.75B
Market cap95.75B
Price-Earnings ratio17.66
Price-Earnings ratio17.66
Dividend yield5.19%
Dividend yield5.19%
Average volume13.13M
Average volume13.13M
High today$47.82
High today$47.82
Low today$46.47
Low today$46.47
Open price$46.65
Open price$46.65
Volume9.84M
Volume9.84M
52 Week high$63.33
52 Week high$63.33
52 Week low$39.71
52 Week low$39.71
BMY News
TipRanks 6d
Bristol-Myers Squibb’s Ozanimod Study: A Potential Game-Changer for Ulcerative Colitis TreatmentBristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premi...
TipRanks 6d
Pfizer and Bristol-Myers Squibb’s Promising Study on Multiple Myeloma TreatmentBristol-Myers Squibb Company ((BMY)), Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advanta...
TipRanks 6d
Bristol-Myers Squibb’s MORAb-202 Study: A Potential Game-Changer in Cancer TreatmentBristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premi...
Analyst ratings
71%
of 28 ratingsBuy
25%
Hold
71.4%
Sell
3.6%
People also own
Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.